Home/ Supplements/ Phosphorus/ Cellmass Grape Cooler

Cellmass Grape Cooler

product on market Powder BSN Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 10% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The product primarily provides carbohydrates and sugars to support energy replenishment and phosphorus and calcium for bone and cellular function. There is strong evidence for the role of these macronutrients and minerals in metabolic support. However, overall evidence coverage for this specific ingredient profile is very limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Cellmass Grape Cooler
Open Full PDF View on NIH DSLD →
Details

Label Data

16 Gram(s)
Serving Size
40
Servings
Other Combinations
Product Type
10%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
30 {Calories}
Total Carbohydrates
7 g (2% DV)
Sugar
Calcium
250 mg (25% DV)
430 mg (43% DV)
Within RDA (0.6× RDA) 13 studies (A:0, B:3)
Sodium
250 mg (10% DV)
Potassium
140 mg (4% DV)
AVPT
4250 mg
2000 mg
Market median: 420.0mg (227 products)
Muscle Cell Uptake Proprietary Matrix
950 mg

Other Ingredients

Glucose Polymers Calcium Silicate Natural & Artificial flavors Citric Acid Potassium Citrate Sucralose FD&C Red #40 and FD&C Blue #1
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

NOTE: To maximize the effects of CELLMASS(R) consume 120 oz. of water per day and a diet that is rich in protein and carbohydrates. Your body chemistry and weight will determine how long it takes to experience the effects of CELLMASS(R). Many users may notice the effects within the first 3-7 days of recommended use. Each week thereafter, the effects will become more pronounced. Other users may notice the inital effects after 7-14 days of use. Again, the effects will become more pronounced each week thereafter. CELLMASS(R) begins to induce its maximum effects in weeks 3-12. After 12 weeks of use, discontinue for at least 4 weeks.

NOTE: To prevent settling, stir vigorously and drink immediately. To ensure maximum results: wait 20-30 minutes after taking CELLMASS(R) before eating a meal or drinking a shake; it is also suggested to use this product in full within a 30 day period.

RECOMMENDED USE ON NON-TRAINING DAYS: Serving 1: As a dietary supplement, mix 1 scoop with 4-6 oz. of cold water or any beverage of your choice upon waking (on an empty stomach). Serving 2: As a dietary supplement, mix 1 scoop with 4-6 oz. of cold water or any beverage of your choice, 6-8 hours after yourfirst serving (on an empty stomach).

RECOMMENDED USE ON TRAINING DAYS: Serving 1: As a dietary supplement, mix 1 scoop with 4-6 oz. of cold water or any beverage of your choice immediately following your workout (on an empty stomach). Serving 2: As a dietary supplement, mix 1 scoop with 4-6 oz. of cold water or any beverage of your choice, 6-8 hours before or after your post-workout serving (on an empty stomach).

Warnings & Precautions

Keep out of reach of children and pets.

Do no use if you are pregnant, nursing, prone to dehydration, or exposed to excessive heat.

Allergen Warning: Manufactured on equipment, which processes products containing milk, egg, soybeans, wheat, shellfish, fish oil, tree nuts, and peanut flavor.

Please be aware this product contains the naturally occurring amino acid Beta-Alanine, which may cause a tingling skin sensation in some individuals similar to niacin flush. This effect should diminish after a few hours and should ultimately subside after days of continuous use. Although rare, individuals with the genetic disorder hyper Beta-Alaninemia should not use this product.

Reduce or dicontinue use if excessive sleeplessness, tremors, dizziness, nervousness, headaches, or heart palpitations occur.

WARNING: Before consuming CELLMASS(R) seek advice from a health care practitioner if you are unaware of your current health condition or have any pre-existing medical condition including but not limited to: high or low blood pressure, cardiac arrhythmia, storke; heart, liver, or thyroid disease; anxiety, depression, seizure diorder, psychiatric disease, diabetes, pernicious anemia, difficulty urinating due to prostate enlargement, or if you are taking an MAO inhibitor or any other medication.

Formulation Notes

CELLMASS(R) is only intended for use by healthy adults 18 years of age or older.

DESIGNED FOR: Healthy persons under 18 years and older seeking to support lean mass, recovery, and tissue repair after strenuous exercise or while sleeping.*

ASPARTAME FREE

ZERO SUGAR

Additional Information

Do not store in direct sunlight, store in a cool dry place.

Store in a cool dry place!

AVPT MULTI-ACTION MATRIX

CORE SERIES

Due to settling, a natural occurrence with powders, variations in the powder height level may vary from bottle to bottle. Additionally, powder density may be affected as a result of the settling which may cause slight variations in the scoop serving size.

Made in USA

MASS* - STRENGTH* - HARDNESS* - MUSCULARITY* - PERFORMANCE* - RECOVERY*

NET WEIGHT

POST-TRAINING/NIGHTTIME MASS & RECOVERY ACTIVATOR*

V.1.215.1105US

Metadata

Product Details

UPC / SKU8 34266 00215 3
DSLD Entry Date2011-11-25
Product TypeOther Combinations
FormPowder
BrandBSN
DSLD ID2298
Data Updated2026-04-11
Research

Research Evidence

46
Research Sources
55
Avg Quality
23
Meta Analysis
7
Systematic Review
7
Rct
4
Clinical Trial
2
Other
1
Guideline
1
Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017 PubMed DOI
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020 PubMed DOI
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018 PubMed DOI
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022 PubMed DOI
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022 PubMed DOI
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024 PubMed DOI
View all evidence for Phosphorus →
Compare

Similar Products

View all Phosphorus products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.